Extended outcomes of adjuvant accelerated partial breast irradiation show excellent tumor control, breast cosmesis, minimal late toxicity

Long-term (five-year) outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation (APBI) after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study.